[Intravenous ketamine in suicidal crisis : indications and patient referral].
Abstract
Intravenous (IV) ketamine is a rapidly acting therapeutic option for the management of treatment-resistant depression and acute suicidal crisis. Unlike conventional antidepressants, its effects may occur within hours, allowing a rapid reduction in suicidal ideation and psychological distress. Its use remains specialized and requires hospital-based care with medical monitoring and a comprehensive psychiatric assessment. This article provides a practical overview for primary care physicians, focusing on the indications, referral criteria, and role of IV ketamine within the care pathway of patients with treatment-resistant depression or acute suicidal crisis, illustrated by a clinical vignette.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.